Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
2.505
-0.035 (-1.38%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Mereo BioPharma Group Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
69.857.4268.18126.9131.3
Upgrade
Short-Term Investments
---0.770.75
Upgrade
Cash & Short-Term Investments
69.857.4268.18127.6832.04
Upgrade
Cash Growth
21.56%-15.78%-46.60%298.48%48.00%
Upgrade
Other Receivables
2.793.132.312.465.78
Upgrade
Receivables
2.793.132.312.465.78
Upgrade
Prepaid Expenses
0.330.973.783.792.21
Upgrade
Other Current Assets
1.852.230.920.550.56
Upgrade
Total Current Assets
74.7663.7675.2134.4940.58
Upgrade
Property, Plant & Equipment
0.981.652.223.432.15
Upgrade
Other Intangible Assets
0.641.09-33.2643.21
Upgrade
Total Assets
76.3966.577.41171.1885.94
Upgrade
Accounts Payable
2.682.353.493.094.32
Upgrade
Accrued Expenses
4.575.755.645.445.9
Upgrade
Current Portion of Long-Term Debt
5.54-13.33--
Upgrade
Current Portion of Leases
0.710.650.560.840.87
Upgrade
Current Income Taxes Payable
---2.06-
Upgrade
Other Current Liabilities
0.360.741.365.550.6
Upgrade
Total Current Liabilities
13.859.4924.3816.9811.69
Upgrade
Long-Term Debt
-4.39-19.4822.04
Upgrade
Long-Term Leases
0.190.911.482.381.58
Upgrade
Other Long-Term Liabilities
1.391.180.1613.1871.07
Upgrade
Total Liabilities
15.4215.9626.0152.02106.38
Upgrade
Common Stock
3.062.782.482.381.39
Upgrade
Additional Paid-In Capital
539.64486.11476.52335.08220.88
Upgrade
Retained Earnings
-462.88-419.63-404.58-402.11-422.82
Upgrade
Treasury Stock
--1.23-1.34--
Upgrade
Comprehensive Income & Other
-18.85-17.49-21.69183.82180.11
Upgrade
Shareholders' Equity
60.9750.5451.4119.16-20.44
Upgrade
Total Liabilities & Equity
76.3966.577.41171.1885.94
Upgrade
Total Debt
6.435.9515.3722.6924.49
Upgrade
Net Cash (Debt)
63.3751.4752.81104.997.55
Upgrade
Net Cash Growth
23.13%-2.54%-49.70%1289.80%-
Upgrade
Net Cash Per Share
0.430.390.440.950.11
Upgrade
Filing Date Shares Outstanding
159140.01124.74116.73108
Upgrade
Total Common Shares Outstanding
155.15140124.74116.7367.54
Upgrade
Working Capital
60.9254.2750.82117.5128.89
Upgrade
Book Value Per Share
0.390.360.411.02-0.30
Upgrade
Tangible Book Value
60.3349.4551.485.9-63.65
Upgrade
Tangible Book Value Per Share
0.390.350.410.74-0.94
Upgrade
Machinery
0.490.50.610.480.28
Upgrade
Leasehold Improvements
0.710.710.680.750.22
Upgrade
Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q